EFTR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own EFTR shares is 7, representing 5.93% of the company's common stock.

BLACKSTONE INC., in the last quarter, reduced its stake in EFTR by -96% restricting it's holding to 52.34 thousand shares of worth nearly $753.22K. JPMORGAN CHASE & CO also lessened -100% of the EFTR shares from its portfolio, reducing its holding to 0 shares of worth -. BANK OF AMERICA CORP /DE/ also shunned EFTR shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, ALYESKA INVESTMENT GROUP, L.P. increased its stake in EFTR by 100% in the last quarter. The institutional holder raised its holding to 364.93 thousand shares having worth more than $4.26M. NORTHERN TRUST CORP also added 336.82% more shares of EFTR to its portfolio, raising its holding to 160.81 thousand shares of worth $75.16K. TWO SIGMA SECURITIES, LLC also increased its EFTR shares holding by 100% which brought its holding to 61.69 thousand shares worth $28.84K.

The insider with the most stakes in EFTR is SR ONE CAPITAL MANAGEMENT, LLC , 10 percent owner at the company. Additionally, EFTR stock is highly held by President and Chief Executive WORLAND STEPHEN T and ROOT JONATHAN D among others.

Company executives, directors, and other insiders own 2.91% percent of eFFECTOR Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which EFTR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SR ONE CAPITAL MANAGEMENT, LLC, PRESIDIO MANAGEMENT GROUP X LLC, and ROOT JONATHAN D.

There have been 0 transaction(s) during the past 6-months in which eFFECTOR Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 eFFECTOR Therapeutics, Inc. shares are held by insiders, which represents about 2.91% of EFTR stock.

EFTR 10 percent owner, SR ONE CAPITAL MANAGEMENT, LLC holds the largest portfolio of the company's shares. EFTR shares owned by SR total nearly 1.82 million.

BLACKSTONE INC. is the largest institutional owner in EFTR which holds 52.34 thousand shares worth $753.22K or 2.39% of the total EFTR shares outstanding followed by JPMORGAN CHASE & CO with ownership of 0 shares representing 0% of the EFTR ownership. BANK OF AMERICA CORP /DE/ is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the EFTR is concerned, it is a stock which is not optionable.

Number of EFTR shares short is 91.62K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 4.70M shares of EFTR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, EFTR has 4.23M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for EFTR is 0.97.